Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY23 results · Jul–Sep 2022
Max Healthcare Institute reported revenue from operations of ₹1,137.12 crore (up 11.7% from Q2 FY22) and net profit of ₹457.35 crore (up 216.2% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,137.12 | 1,018.33 | +11.7% | 1,066.27 | +6.6% |
| Other income | 25.82 | 31.31 | −17.5% | 31.51 | −18.1% |
| Total income | 1,162.94 | 1,049.64 | +10.8% | 1,097.78 | +5.9% |
| Profit before tax | 265.22 | 181.62 | +46.0% | 216.38 | +22.6% |
| Net profit for the period | 457.35 | 144.65 | +216.2% | 172.83 | +164.6% |
| EPS, basic (₹) | 4.72 | 1.50 | +214.7% | 1.78 | +165.2% |
| Net margin (%) | 40.2 | 14.2 | 16.2 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 474.14 | 449.95 | +5.4% | 426.55 | +11.2% |
| Other income | 32.16 | 28.16 | +14.2% | 28.77 | +11.8% |
| Total income | 506.30 | 478.11 | +5.9% | 455.32 | +11.2% |
| Profit before tax | 144.01 | 95.82 | +50.3% | 109.94 | +31.0% |
| Net profit for the period | 358.64 | 73.25 | +389.6% | 85.26 | +320.6% |
| EPS, basic (₹) | 3.70 | 0.76 | +386.8% | 0.88 | +320.5% |
| Net margin (%) | 75.6 | 16.3 | 20.0 |
Consolidated
- Filed with BSE
- 01 Nov 2022, 17:11 IST
- Board meeting
- 01 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Nov 2022, 17:11 IST
- Board meeting
- 01 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE